Medicenna Therapeutics Corp (MDNA : TSX)
Common Stock
$0.36
CAD
+0.01 (2.86%)
Last updated: 2026-07-31
Get MDNA alerts:
MDNA
Medicenna Therapeutics Corp
Performance
1 Day
+2.86%
1 Week
+2.86%
1 Month
-8.86%
YTD
-64.00%
Key Statistics
Market Cap
$33.23M
52W High
$1.97
52W Low
$0.34
P/E Ratio
-
50 Day MA
$0.40
200 Day MA
$0.82
Beta
1.89
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/31/2026 | $0.34 | $0.36 | $0.34 | $0.36 | $0.36 | 14,480 |
| 7/30/2026 | $0.35 | $0.35 | $0.34 | $0.35 | $0.35 | 79,482 |
| 7/29/2026 | $0.36 | $0.36 | $0.34 | $0.35 | $0.35 | 25,054 |
| 7/28/2026 | $0.35 | $0.35 | $0.35 | $0.35 | $0.35 | 34,103 |
| 7/27/2026 | $0.36 | $0.36 | $0.34 | $0.34 | $0.34 | 75,808 |
| 7/24/2026 | $0.35 | $0.35 | $0.35 | $0.35 | $0.35 | 13,732 |
| 7/23/2026 | $0.35 | $0.35 | $0.34 | $0.34 | $0.34 | 17,082 |
| 7/22/2026 | $0.35 | $0.35 | $0.34 | $0.35 | $0.35 | 30,054 |
| 7/21/2026 | $0.35 | $0.35 | $0.34 | $0.35 | $0.35 | 30,502 |
| 7/20/2026 | $0.35 | $0.35 | $0.34 | $0.35 | $0.35 | 49,968 |
Analyst Price Targets
Based on analyst covering MDNA
Wall Street analysts forecast MDNA stock price to rise 788.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.20
+788.9% Upside
Current Price
C$0.36
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDNA's historical volatility
30-Day Vol
34.7%
Annualized
90-Day Vol
67.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.30
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.34 | C$0.30 – C$0.38 |
| 60 trading days | C$0.32 | C$0.27 – C$0.38 |
| 90 trading days | C$0.30 | C$0.24 – C$0.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Medicenna Therapeutics Corp
Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, an interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; and MDNA113, a tumor-targeting and activatable bifunctional anti-PD-1-IL-2 superkine for cancer. In addition, its preclinical products are MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases, including transplant rejection; and MDNA413, an IL-4/IL-13 antagonist to inflammatory, asthma, and atopic dermatitis, as well as other allergic diseases. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-22.40M
- Profit Margin
- 0.00%
- ROE (TTM)
- -170.64%
- EPS (Diluted)
- -0.22
- Book Value
- 0.03
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About MDNA
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| TC | Tucows Inc. | $21.73 | +58.85% |
| PPR | Prairie Provident Resources Inc | $0.45 | +30.43% |
| BHC | Bausch Health Companies Inc | $9.65 | +14.47% |
| CJR-B | Corus Entertainment Inc | $0.04 | +14.29% |
| RTG | RTG Mining Inc | $0.04 | +14.29% |
| GTE | Gran Tierra Energy Inc | $10.52 | +12.15% |
| FSY | Forsys Metals Corp. | $0.49 | +11.36% |
| TVA-B | TVA Group Inc | $2.31 | +10.53% |
MDNA.TO news timeline
15 articles covering MDNA.TO, most recent first
LatestWhy Medicenna Therapeutics Corp stock is rising today
July 2026
- Why Medicenna Therapeutics Corp stock is rising today
- What's Going On With Medicenna Therapeutics Corp Stock Wednesday?
- Why Medicenna Therapeutics Corp stock is rising today
- What's Going On With Medicenna Therapeutics Corp Stock Wednesday?
- Why Medicenna Therapeutics Corp stock is sliding today
- Why Medicenna Therapeutics Corp stock is sliding today
- Why Medicenna Therapeutics Corp stock is sliding today
- Why Medicenna Therapeutics Corp stock is sliding today
- Why Medicenna Therapeutics Corp stock is sliding today